Jacobsen Capital Management’s AbbVie ABBV Stock Holding History

Jacobsen Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$921K	Buy	3,660 +27	+0.7%	+$5.81K	0.27%	38
2026 Q1	$790K	Sell	3,633 -1	-0%	-$222	0.27%	34
2025 Q4	$830K	Sell	3,634 -63	-2%	-$14.4K	0.27%	34
2025 Q3	$856K	Buy	3,697 +7	+0.2%	+$1.43K	0.29%	33
2025 Q2	$685K	Buy	3,690 +385	+12%	+$71.6K	0.25%	38
2025 Q1	$693K	Buy	3,305 +51	+2%	+$9.91K	0.3%	34
2024 Q4	$578K	Buy	3,254 +106	+3%	+$19.5K	0.25%	40
2024 Q3	$622K	Buy	3,148 +470	+18%	+$87.7K	0.26%	39
2024 Q2	$459K	Sell	2,678 -104	-4%	-$17.2K	0.21%	45
2024 Q1	$507K	Buy	2,782 +348	+14%	+$60K	0.24%	41
2023 Q4	$377K	Sell	2,434 -215	-8%	-$31.3K	0.19%	48
2023 Q3	$395K	Buy	2,649 +623	+31%	+$91.5K	0.21%	48
2023 Q2	$273K	Sell	2,026 -575	-22%	-$84.3K	0.14%	60
2023 Q1	$415K	Buy	+2,601	New	+$398K	0.22%	45

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Jacobsen Capital Management's ABBV Position: Q2 2026 in Review

Jacobsen Capital Management increased its AbbVie (ABBV) stake by 0.74% in Q2 2026, buying an estimated $5.81K and bringing the position to 3,660 shares worth $921K. The position accounts for 0.27% of the portfolio, ranked #38.

Jacobsen Capital Management first reported a position in ABBV in Q1 2023 and has held it in 14 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Jacobsen Capital Management held 3,660 shares of AbbVie worth $921K as of Q2 2026.
Jacobsen Capital Management bought 27 AbbVie shares in Q2 2026, an estimated $5.81K.
AbbVie made up 0.27% of Jacobsen Capital Management's portfolio in Q2 2026, its #38 holding.
Jacobsen Capital Management first reported a position in AbbVie in Q1 2023 and has held it in 14 quarters since.
4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Jacobsen Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.